GLOBAL NEWS: CureVac COVID-19 vaccine hits just 48% efficacy in final analysis
CureVac COVID-19 vaccine hits just 48% efficacy in final analysis
German biotech company CureVac announced its COVID-19 vaccine demonstrated 48% efficacy against COVID-19 of any severity in a final readout of late-stage trial data.
Baca Juga:
via FOX NEWS https://ift.tt/3ycEI6L
Belum ada Komentar untuk "GLOBAL NEWS: CureVac COVID-19 vaccine hits just 48% efficacy in final analysis"
Posting Komentar